Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug:216:A1-A2.
doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?

Michael F Marmor  1
Affiliations
Editorial

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?

Michael F Marmor. Am J Ophthalmol. 2020 Aug.
No abstract available

PubMed Disclaimer

References

    1. Devaux C.A., Rolain J.-M., Colson P., Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105938. - DOI - PMC - PubMed
    1. Gao J., Zhenxue T., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 2020;14:72–73. - PubMed
    1. Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020;38:379–381. - PubMed
    1. Marmor M., Kellner U., Lai T.Y., Melles R.B., Mieler W.F. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) Ophthalmology. 2016;123:1386–1394. - PubMed
    1. Furst D.E., Lindsley H., Baethge B. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. Semin Arthritis Rheum. 1999;42:357–365. - PubMed

Publication types

MeSH terms